Found 7 matching trials
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer PHASE2 This study will monitor the safety of novel immunotherapy combinations in p...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors PHASE1 This first-time-in-human (FTIH) study will evaluate the safety, tolerabilit...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors PHASE1 This is a multicenter, open-label, phase I/II basket study, evaluating the ...
Show More Location
University of California San Diego
Learn More & Join Trial
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) PHASE2 This study will compare the clinical activity of novel regimens (in combina...
Show More Location
GSK Investigational Site
Learn More & Join Trial
First-In-Human Study of EOS884448 in Participants with Advanced Cancers. PHASE1 IO-002 study is a multicenter, open-label, dose-escalation Phase I/IIa clin...
Show More Location
GZA Ziekenhuizen campus Sint-Augustinus
Learn More & Join Trial
Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma PHASE1 This is a multicenter, open-label, phase I/II clinical study, to assess the...
Show More Location
Banner MD Anderson
Learn More & Join Trial
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) PHASE3 The goal of this clinical trial is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial